7Baggers
 Why Kymera Therapeutics Shares Are Gaining Attention  TipRanks Fri, 14 Nov 2025 16:24:16 GMT
 kymera at td cowen summit: strategic moves in immunology  Investing.com Thu, 13 Nov 2025 17:44:14 GMT
 kymera therapeutics stock hits 52-week high at 64.0 usd by investing.com  Investing.com Philippines Wed, 12 Nov 2025 10:29:21 GMT
 kymera at stifel conference: strategic insights on drug development  Investing.com Tue, 11 Nov 2025 20:30:29 GMT
 Kymera Therapeutics stock hits 52-week high at 64.0 USD  Investing.com Tue, 11 Nov 2025 19:58:15 GMT
 kymera at ubs global healthcare conference: strategic insights  Investing.com Mon, 10 Nov 2025 18:48:11 GMT
 kymera at guggenheim conference: strategic innovations in healthcare  Investing.com Mon, 10 Nov 2025 15:50:42 GMT
 what is hc wainwright's forecast for kymr fy2025 earnings?  MarketBeat Sat, 08 Nov 2025 13:12:21 GMT
 kymr fy2025 eps raised by brookline capital management  MarketBeat Sat, 08 Nov 2025 13:12:21 GMT
 equities analysts set expectations for kymr fy2025 earnings  MarketBeat Sat, 08 Nov 2025 13:12:20 GMT
 B. Riley Predicts Stronger Earnings for Kymera Therapeutics  MarketBeat Sat, 08 Nov 2025 08:00:00 GMT
 Kymera Therapeutics (NASDAQ:KYMR) Upgraded at Wall Street Zen  MarketBeat Sat, 08 Nov 2025 08:00:00 GMT
 kymera therapeutics (kymr) gets a buy from rbc capital  The Globe and Mail Fri, 07 Nov 2025 10:19:49 GMT
 oppenheimer raises kymera therapeutics stock price target ahead of phase 1b readout  Investing.com Australia Wed, 05 Nov 2025 20:20:27 GMT
 Kymera Therapeutics (KYMR): Barclays Raises Price Target to $70.  GuruFocus Wed, 05 Nov 2025 18:13:26 GMT
 kymera therapeutics (nasdaq:kymr) posts quarterly earnings results  MarketBeat Wed, 05 Nov 2025 16:04:11 GMT
 Wells Fargo Raises Price Target for Kymera Therapeutics (KYMR) |  GuruFocus Wed, 05 Nov 2025 15:47:36 GMT
 Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2025 Earnings Call Transcript  Insider Monkey Wed, 05 Nov 2025 13:29:13 GMT
 Kymera Therapeutics stock price target raised to $84 from $70 at H.C. Wainwright  Investing.com Nigeria Wed, 05 Nov 2025 12:39:55 GMT
 kymr stock: hc wainwright & co. raises price target to $84 | kym  GuruFocus Wed, 05 Nov 2025 12:26:37 GMT
 10 Analysts Have This To Say About Kymera Therapeutics  Benzinga Wed, 05 Nov 2025 11:45:40 GMT
 decoding kymera therapeutics inc (kymr): a strategic swot insigh  GuruFocus Wed, 05 Nov 2025 05:37:56 GMT
 kymera therapeutics reports q3 2025 financial results  TipRanks Wed, 05 Nov 2025 04:16:29 GMT
 kymera therapeutics q3 2025 earnings call transcript  MarketBeat Tue, 04 Nov 2025 15:56:15 GMT
 kymera therapeutics q3 loss widens, revenue falls  MarketScreener Tue, 04 Nov 2025 13:10:35 GMT
 Kymera Therapeutics Inc Q3 2025 Earnings: EPS of -$0.94 Misses E  GuruFocus Tue, 04 Nov 2025 12:57:19 GMT
 kymera therapeutics reports q3 eps (94c), consensus (79c)  TipRanks Tue, 04 Nov 2025 12:34:09 GMT
 kymera therapeutics q3 2025 earnings preview  MSN Tue, 04 Nov 2025 10:06:30 GMT
 Kymera Therapeutics Reports Q3 2025 Financial Results  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 Decoding Kymera Therapeutics Inc (KYMR): A Strategic SWOT Insigh  GuruFocus Tue, 04 Nov 2025 08:00:00 GMT
 kymera therapeutics, inc. (kymr) q3 fy2025 earnings call transcript  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 kymera therapeutics q3 2025 earnings preview  MSN Mon, 03 Nov 2025 16:34:39 GMT
 Guggenheim Assumes Buy Rating for Kymera Therapeutics (KYMR) | K  GuruFocus Mon, 03 Nov 2025 14:03:45 GMT
 Kymera Therapeutics to Participate in Upcoming November Investor Conferences  Investing News Network Mon, 03 Nov 2025 13:03:36 GMT
 kymera therapeutics assumed with a buy at guggenheim  TipRanks Mon, 03 Nov 2025 08:00:00 GMT
 kymera therapeutics faces critical earnings test  AD HOC NEWS Sat, 01 Nov 2025 10:09:04 GMT
 kymera therapeutics price target raised to $72 from $54 at bofa  TipRanks Fri, 31 Oct 2025 14:39:31 GMT
 Kymera Therapeutics (NASDAQ:KYMR) CEO Sells $1,829,700.00 in Stock  MarketBeat Thu, 30 Oct 2025 07:00:00 GMT
 Kymera Therapeutics Advances KT-621 Study for Atopic Dermatitis  TipRanks Mon, 27 Oct 2025 07:00:00 GMT

Kymera Therapeutics, Inc
(NASDAQ:KYMR) 

KYMR stock logo

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase...

Founded: 2016
Full Time Employees: 64
CEO: Nello Mainolfi  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends